Dexcom, the maker of continuous blood glucose monitors, is developing a Type 2 diabetes monitor for people who don’t need insulin with a 15-day sensor and a cash payment option for patients who don’t have access to insulin. Medicare and the health insurance companies that pay for it want an up-to-date decision.
With the number of Americans affected by diabetes reaching more than 37 million, according to the US Centers for Disease Control, healthcare technology developers and researchers seek to increase prevention, detection, and prevention. early, diabetes management and care.
Kevin Sayer, CEO of Dexcom, said: “There are three key decisions that a person with Type 2 diabetes who does not take insulin makes. San Diego Union-Tribune.
“Those decisions are exercise, food, and medication.”
According to reports, Sayers told attendees at the American Diabetes Conference in San Diego that the company’s new sensor – which is about a year away from being on the market – will help millions of patients. manage Type 2 diabetes without insulin and it will help millions of people with diabetes. Patients learn how their daily routine affects their condition.
According to researchers at the University of Utah School of Medicine, the Regenstrief Institute and Hitachi, while 10 percent of adults worldwide are diagnosed with type 2 diabetes, a smaller percentage require multiple medications. to control blood sugar and avoid serious complications. to the use of artificial intelligence to analyze electronic health record data for T2DM characteristics.
“With this system, they can see their meal plan. They can see their exercise. They can see any medication they take – be it diabetes or medication for diseases. other,” Sayers explained of the new wearable medical device Dexcom is in development and is being reviewed by the US government.
In general, wearable blood glucose monitors should show how they can help reduce costs across the healthcare system, he said.
“A quarter of US dollars spent on health care is spent on diabetes,” he said.
“The only way to change these trends is to give people information that can help their health better.”
Dexcom also announced on Tuesday that its G7 CGM, features predictive emergency alerts in addition to real-time alerts for people using insulin to manage their diabetes. , has received approval from Health Canada.
CGM equipment received US market approval in December. In January, Sayers said MobiHealthNews that with the arrival of the new G7 platform, Dexcom CGM has become “interoperable and connectable” with greater cybersecurity.
Andrea Fox is the senior editor of Healthcare IT News.
Email: [email protected]
Healthcare IT News is a publication of HIMSS Media.
